Clinical Trial Update: Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update indicates completion of a study evaluating escitalopram in patients with depression and acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Chonnam National University Hospital | Conditions: Depressive Disorder, Coronary Disease | Phase 4 | Status: COMPLETED